NGM Biopharmaceuticals Secures $13,485,015 Series C Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=74ec0e1c-ede4-4d10-a71a-9411385c51d6&Preview=1 - Date
5/3/2013 - Company Name
NGM Biopharmaceuticals - Mailing Address
630 Gateway Blvd South San Francisco, CA 94080 - Company Description
NGM is a privately-held drug discovery company committed to the identification and development of transformational biologics for diabetes, obesity, muscle wasting and other cardiometabolic diseases. - Website
http://www.ngmbio.com - Transaction Type
Venture Equity - Transaction Amount
$13,485,015 - Transaction Round
Series C - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
